0001593968-18-000934.txt : 20180620 0001593968-18-000934.hdr.sgml : 20180620 20180620140518 ACCESSION NUMBER: 0001593968-18-000934 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180618 FILED AS OF DATE: 20180620 DATE AS OF CHANGE: 20180620 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wotton Paul K CENTRAL INDEX KEY: 0001300997 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35280 FILM NUMBER: 18909258 MAIL ADDRESS: STREET 1: C/O ANTARES PHARMA, INC. STREET 2: 707 EAGLEVIEW BOULEVARD, SUITE 414 CITY: EXTON STATE: PA ZIP: 19341 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vericel Corp CENTRAL INDEX KEY: 0000887359 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943096597 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 7349305555 MAIL ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC DATE OF NAME CHANGE: 19960428 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2018-06-18 0000887359 Vericel Corp VCEL 0001300997 Wotton Paul K C/O VERICEL CORPORATION 64 SIDNEY STREET CAMBRIDGE MA 02139 true false false false Common Stock 2018-06-18 4 M false 5000 3.74 A 5000 D Common Stock 2018-06-18 4 M false 10000 2.76 A 15000 D Common Stock 2018-06-18 4 M false 15000 3.74 A 30000 D Common Stock 2018-06-18 4 S false 10000 12.06 D 20000 D Common Stock 2018-06-18 4 S false 15000 12.06 D 5000 D Common Stock 2018-06-18 4 S false 5000 12.06 D 0 D Stock Option (right to buy) 3.74 2018-06-18 4 M false 5000 0 D 2015-03-20 2025-03-20 Common Stock 5000 0 D Stock Option (right to buy) 2.76 2018-06-18 4 M false 10000 0 D 2016-05-04 2026-05-04 Common Stock 10000 5000 D Stock Option (right to buy) 3.74 2018-06-18 4 M false 15000 0 D 2015-03-20 2025-03-20 Common Stock 15000 0 D The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2018. The options, representing a right to purchase a total of 5,000 shares, became exercisable in twelve equal monthly installments beginning on March 20, 2015, which was the date on which the option was granted. The options, representing a right to purchase a total of 10,000 shares, became exercisable in twelve equal monthly installments beginning on May 4, 2016, which was the date on which the option was granted. The options, representing a right to purchase a total of 15,000 shares, became exercisable in thirty six equal monthly installments beginning on March 20, 2015, which was the date on which the option was granted. /s/ Dominick C. Colangelo, Attorney-in-Fact for Paul Wotton 2018-06-20